pengantar klinik 1 (Revisi 2012)

download pengantar klinik 1 (Revisi 2012)

of 52

Transcript of pengantar klinik 1 (Revisi 2012)

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    1/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    2/52

    PATHOLOGY

    EXAMINATIONDepartment of Pathology

    Medicine Faculty Brawijaya University

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    3/52

    KasusAn. EC/ 2 tahunKeluhan utama: benjolan di kepaladan mata kiri, cepat membesar

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    4/52

    ?

    DIAG

    NOSIS

    HISTORYTAKING

    PHYSEXAM

    LABEXAM

    REXAM

    PA

    EXAM

    THERAPY

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    5/52

    CT Scan KepalaBrain Window

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    6/52

    HASIL FNAB pada Lesi diKepala

    Rosette

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    7/52

    Makroskopik:Tampak tumor di kepala yang meluas ke pelipis dan zygoma

    Mikroskopik:Hapusan hiperseluler terdiri dari sebaran sel-sel ganas berinti bulatkecil-kecil sebagian mengandung nucleoli prominen, sebagiantampak hyperkromatik dengan sitoplasma tipis. Sel-sel tersusunsebagian seperti Rosette dan Sebagian tampak tersebar difus.

    Kesimpulan:MALIGNANT SMALL ROUND CELL TUMOR kemungkinanEWING SARCOMA.

    DD: 1. NEUROBLASTOMA2. LYMPHOMA MALIGNA

    SARAN: Open Biopsi Histo PA

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    8/52

    USG Abdomen

    Massa solid heterogen pada suprarenal kiriSugestif Maligna

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    9/52

    Marker VMA : Negatif

    WDx: NEUROBLASTOMA Stage IV

    Terapi: Kemoterapi dengan Doxorubicin

    Hasil: Perbaikan, massa primer dan metastatik pada skull

    mengecil, BB bertambah.

    Pasien kontrol poli hematologi untuk kemoterapilanjutan.

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    10/52

    Anatomic PathologyExaminations

    Histopathologic Ex.- HistoPA routineFrozensection(Vries

    Coupe)- Pathology autopsy

    Cytologic Ex.- Exfoliative Cytl

    :Gyn and non gyn- FNAB

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    11/52

    Histopathology Examination

    Specimen from operation ( mastectomy, TAHBSO, appendectomy ,colon resection,nephrectomy, thyroidectomy etc .

    Excisional biopsy ( FAM, polyp < 3 cm)

    Incisional biopsy ( tumors > 3 cm ).

    Curretage ( from uterus , dentigerous cyst, etc ) TURP, TURB

    Autopsy specimens.

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    12/52

    Preparation

    Complete delivery form : patient identity,specimen type, fixation, location, clinicaldiagnosis, complete clinical information + draw

    location and size of tumor, history of the diseaseand lab examination.

    Fixation with 10 % formalin.

    Specimen label : name, regist number.

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    13/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    14/52

    Receive specimens from patient

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    15/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    16/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    17/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    18/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    19/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    20/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    21/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    22/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    23/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    24/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    25/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    26/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    27/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    28/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    29/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    30/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    31/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    32/52

    Frozen Section

    Durante op ,Without fixation.

    From : ovary tumor, breast tumor, thyroid tumor, skin

    tumor, brain tumor, Hirschsprung disease. Decided benign or malignant, free margins

    Operation technic ( therapy management).

    GOLD STANDARD DX : histopathology paraffin block

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    33/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    34/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    35/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    36/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    37/52

    HASIL VRIESCOUPE :Ganas

    (Infiltrating Ductal

    Carcinoma)

    /

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    38/52

    IMMUNOHISTO/CYTOCHEMISTRY

    Indication : standard for tx and prognosis,decided tumor type.

    Example : ER/PR, HER2 for Breast Cancer,CD 4,8, 19, 20 for decide Non Hodgkinlymphoma type B or T. Vimentin, LCA, desmin,cytokeratin for differential diagnostic of

    malignant small round cell tumor,determine theorigin of tumor cells .

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    39/52

    ImmunohistokimiaCa. Mammae Her2

    Positif

    ImmunohistokimiaCa. Mammae ER

    Positif

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    40/52

    -year-old manPleural fluid

    Primary site: unknownlungstomach

    Cytological diagnosis:

    Primary lung cancer

    NapsinCK7 CK20

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    41/52

    FINE NEEDLE

    ASPIRATION BIOPSY

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    42/52

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    43/52

    Close biopsy with FNAB

    Simple , economical technique.

    Can be performed as an outpatient procedure.

    Few complications. Multiple sites.

    Rapid diagnosis & treatment planning

    Highly accurate

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    44/52

    FNAB Procedure

    PRECONDITION

    Clinical information.

    Conventional radiograph / CT scan / MRI/USG of the tumor

    Biopsy target can be located with palpation orguided by CT scan/ USG.

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    45/52

    Material and Method

    Needle 25 G/27 G/23G

    Spuit 10cc.

    Object glass.

    Alcohol 70 %

    Alcohol 95%.

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    46/52

    1. Examine patient and Radiograph

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    47/52

    2. Puncture Tumor

    Desinfection.

    Tumor fixation with fingers.

    Puncture tumor without/with aspiration.

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    48/52

    Make smear-fixation-staining

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    49/52

    FNAB diagnostic : GCT of the Bone

    Cli i l Pi A KHA 12 h

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    50/52

    Clinical Pictures: An KHA 12 thn,humeral tumor 6 yr

    X h (24/2/11) RS S if l

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    51/52

    X-ray humerus (24/2/11)RS SaifulAnwar, Malang

  • 7/29/2019 pengantar klinik 1 (Revisi 2012)

    52/52